Dolby Laboratories (DLB) Tops Q1 EPS by 44c, Offers Guidance

Dolby Laboratories (NYSE: DLB) reported Q1 EPS of $1.48, $0.44 better than the analyst estimate of $1.04. Revenue for the quarter came in at $389.9 million versus the consensus estimate of $345.33 million.

GUIDANCE:

Dolby Laboratories sees Q2 2021 EPS of $0.57-$0.72, versus the consensus of $0.62. Dolby Laboratories sees Q2 2021 revenue of $280-310 million, versus the consensus of $290.1 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Genco rejects Diana Shipping bid, calls offer below NAV
• ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)